Department of Pathology Microbiology and Immunology Archive — Page 26 of 31

arm with IV line
June 4, 2015

Study identifies C. diff toxin receptor, suggests new treatment approaches

Vanderbilt University investigators have identified a cellular receptor for a toxin from Clostridium difficile (“C. diff”) — the leading cause of hospital-acquired diarrhea in the United States.

A gloved hand holds a plastic blood bag filled with red blood, labeled “WHOLE BLOOD” and “VOLUNTEER DONOR.”
May 4, 2015

Kids more likely to react to blood transfusions

Pediatric patients have a significantly higher incidence of transfusion reactions compared to adults, according to a study by Vanderbilt University researchers.

Illustration of a neuron with a branching cell body, central nucleus, elongated myelinated axon, and terminal ending against a blurred green background.
April 30, 2015

RNA defects in multiple sclerosis

Vanderbilt researchers have discovered that profound defects exist in the integrity of structural RNA molecules in patients with relapsing remitting multiple sclerosis.

Portrait of a bearded man wearing glasses, a striped shirt, and tie. Visible metadata identifies him as Justin Cates, M.D., Ph.D., in pathology.
April 16, 2015

Cates lands grant to study desmoid tumor genetic factors

The Desmoid Tumor Research Foundation (DTRF) has awarded Justin Cates, M.D., Ph.D., associate professor of Pathology, Microbiology and Immunology, with one of its five research grants for his work studying growth/recurrence determinants related to genetic factors in desmoid-type fibromatosis (DTF) patients.

Portrait of Eric Skaar wearing a black suit, white shirt, and striped tie against a neutral background.
March 19, 2015

Skaar elected to American Academy of Microbiology

Illustration of several spherical virus particles with brown textured surfaces and numerous translucent yellow spike-like projections, shown against a dark reddish-brown background.
February 24, 2015

Contributors to coronavirus ‘fitness’

Understanding the role that host membrane modification plays in coronavirus replication is essential for developing novel approaches to block the viruses that cause SARS and MERS.